EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 3.0

Efficacy and Safety of Oteseconazole in Severe Vulvovaginal Candidiasis Categorized by Candida Species and Previous Genital Tract Infection: A Post Hoc Analysis of a Phase 3 Trial

Xiaoqian Wang, Fengxia Xue, Chunlian Zhang, Ruifang An, Hongjie Ruan, Liancheng Zhu, Liping Zhang, Qinping Liao

Drug Design, Development and Therapy · 2026-06 · Volume 20 · 1-12

DOI: 10.2147/dddt.s599356 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Drug Design, Development and Therapy, 2026-06. Verfasst von Xiaoqian Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Beijing Tsinghua Changgung Hospital, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Antifungal Agents, Candida, Candidiasis, Vulvovaginal, Triazoles. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsCandidaCandidiasis, VulvovaginalTriazolesAdultFemaleHumansFluconazoleMicrobial Sensitivity TestsTreatment OutcomeClinical Trials, Phase III as TopicRandomized Controlled Trials as TopicImidazolesThiophenes

Stichwörter der Autor:innen

Candida speciesoteseconazolepost hoc analysisprevious genital tract infectionsevere vulvovaginal candidiasis

Substanzen

Antifungal AgentsFluconazolesertaconazoleTriazolesImidazolesThiophenes

Autor:innen und Institutionen

  • Department of Gynecology, Beijing Tsinghua Changgung Hospital, Beijing, People's Republic of China.
  • Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
  • Department of Gynecology, Taihe Hospital, Affiliated Hospital of Hubei University of Medicine, Shiyan, People's Republic of China.
  • Department of Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
  • Department of Gynecology, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, People's Republic of China.
  • Department of Gynecology, The Affiliated Shengjing Hospital of China Medical University, Shenyang, People's Republic of China.

Zitieren

APA

Wang, X., Xue, F., Zhang, C., An, R., Ruan, H., Zhu, L., Zhang, L., & Liao, Q. (2026). Efficacy and Safety of Oteseconazole in Severe Vulvovaginal Candidiasis Categorized by Candida Species and Previous Genital Tract Infection: A Post Hoc Analysis of a Phase 3 Trial. Drug Design, Development and Therapy, Volume 20, 1-12. https://doi.org/10.2147/dddt.s599356

Vancouver

Wang X, Xue F, Zhang C, An R, Ruan H, Zhu L, et al. Efficacy and Safety of Oteseconazole in Severe Vulvovaginal Candidiasis Categorized by Candida Species and Previous Genital Tract Infection: A Post Hoc Analysis of a Phase 3 Trial. Drug Design, Development and Therapy. 2026;Volume 20:1-12. doi:10.2147/dddt.s599356

BibTeX
@article{Wang2026,
  author = {Wang, Xiaoqian and Xue, Fengxia and Zhang, Chunlian and An, Ruifang and Ruan, Hongjie and Zhu, Liancheng and Zhang, Liping and Liao, Qinping},
  title = {Efficacy and Safety of Oteseconazole in Severe Vulvovaginal Candidiasis Categorized by Candida Species and Previous Genital Tract Infection: A Post Hoc Analysis of a Phase 3 Trial},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--12},
  doi = {10.2147/dddt.s599356}
}
Kostenlos starten →